A fresh look at coronary microembolization

P Kleinbongard, G Heusch - Nature Reviews Cardiology, 2022 - nature.com
Mechanical stress from haemodynamic perturbations or interventional manipulation of
epicardial coronary atherosclerotic plaques with inflammatory destabilization can release …

Myocardial no-reflow in humans

G Niccoli, F Burzotta, L Galiuto, F Crea - Journal of the American College of …, 2009 - jacc.org
In a variable proportion of patients presenting with ST-segment elevation myocardial
infarction, ranging from 5% to 50%, primary percutaneous coronary intervention achieves …

Thrombus aspiration during primary percutaneous coronary intervention

T Svilaas, PJ Vlaar, IC van der Horst… - New England journal …, 2008 - Mass Medical Soc
Background Primary percutaneous coronary intervention (PCI) is effective in opening the
infarct-related artery in patients with myocardial infarction with ST-segment elevation …

Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction

RW Harrison, A Aggarwal, F Ou, LW Klein… - The American journal of …, 2013 - Elsevier
Previous studies describing the no-reflow phenomenon in patients with acute myocardial
infarction (AMI) undergoing percutaneous coronary intervention (PCI) were largely confined …

Intramyocardial haemorrhage after acute myocardial infarction

RP Betgem, GA De Waard, R Nijveldt… - Nature Reviews …, 2015 - nature.com
In patients with acute myocardial infarction (AMI), the guideline-recommended treatment is
mechanical revascularization by percutaneous coronary intervention (PCI), which is effective …

Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction

JA Goldstein, B Maini, SR Dixon… - Circulation …, 2011 - Am Heart Assoc
Background—Percutaneous coronary intervention (PCI) is associated with periprocedural
myocardial infarction (MI) in 3% to 15% of cases (depending on the definition used). In many …

Coronary no reflow

BG Schwartz, RA Kloner - Journal of molecular and cellular cardiology, 2012 - Elsevier
The no-reflow phenomenon has been studied extensively in the basic science laboratory
and has entered the clinical arena. No-reflow, which develops largely within the first 2h of …

A meta-analytic overview of thrombectomy during primary angioplasty

G De Luca, EP Navarese, H Suryapranata - International journal of …, 2013 - Elsevier
INTRODUCTION: Even though primary angioplasty restores TIMI 3 flow in more than 90% of
STEMI patients, the results in terms of myocardial perfusion are still unsatisfactory in a …

Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement …

I Porto, JB Selvanayagam, WJ Van Gaal, F Prati… - Circulation, 2006 - Am Heart Assoc
Background—Myocardial necrosis can occur during percutaneous coronary intervention
(PCI) despite optimal adjunctive pharmacology and careful technique. We investigated the …

Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation

AO Chen, Z Chen, Y Zhou, Y Wu, Y Xia, D Lu… - Cell Death & …, 2021 - nature.com
Coronary microembolization (CME), a common reason for periprocedural myocardial
infarction (PMI), bears very important prognostic implications. However, the molecular …